Market cap
₹3,273 Cr
Recently Viewed
Clear AllMarket cap
₹3,273 Cr
Revenue (TTM)
₹7,196 Cr
P/E Ratio
18
P/B Ratio
3.7
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹-954 Cr
ROE
-18.6 %
ROCE
-5.5 %
Industry P/E
39.7
EV/EBITDA
4.7
Debt to Equity
0.8
Book Value
₹191.8
EPS
₹-39.2
Face value
2
Shares outstanding
156,338,811
CFO
18,640.82 Cr
EBITDA
15,310.05 Cr
Net Profit
604.90 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
BSE Sensex
| -7.3 | 5.3 | -4.1 | -1.1 | 9.6 | 10.5 | 11.7 |
|
BSE Healthcare
| 0.1 | 2.8 | 5.2 | 3.6 | 24.0 | 13.2 | 10.8 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
No Review & Analysis are available.
--
Incorporated
1984
Chairman
--
Managing Director
--
Group
MNC
Headquarters
Hyderabad, Telangana
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The P/E ratio of Mylan Laboratories Ltd is 18.02 times as on 13-Aug-2009, a 55 discount to its peers’ median range of 39.70 times.
The P/B ratio of Mylan Laboratories Ltd is 3.69 times as on 13-Aug-2009, a 1 discount to its peers’ median range of 3.72 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
0.00
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
The 52-week high and low of Mylan Laboratories Ltd are Rs -- and Rs -- as of 23-Apr-2026.
Mylan Laboratories Ltd has a market capitalisation of ₹ 3,273 Cr as on 13-Aug-2009. As per SEBI classification, it is a company.
Before investing in Mylan Laboratories Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.